{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:34:49Z","timestamp":1769628889350,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.neuropharm.2007.08.018","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T11:23:07Z","timestamp":1188991387000},"page":"881-889","source":"Crossref","is-referenced-by-count":40,"title":["Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells"],"prefix":"10.1016","volume":"53","author":[{"given":"Toshihiko","family":"Yanagita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Maruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Uezono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norie","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.08.018_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0014-5793(99)00685-7","article-title":"Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration","volume":"453","author":"Alvarez","year":"1999","journal-title":"FEBS Letters"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1085\/jgp.67.3.295","article-title":"Ionic selectivity of the sodium channel of frog skeletal muscle","volume":"67","author":"Campbell","year":"1976","journal-title":"Journal of General Physiology"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"26","author":"Catterall","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0300-9084(00)01174-3","article-title":"Molecular mechanisms of neurotoxin action on voltage-gated sodium channels","volume":"82","author":"Cest\u00e8le","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tips.2005.08.002","article-title":"Regulation of NaV channels in sensory neurons","volume":"26","author":"Chahine","year":"2005","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib6","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3\u03b2 phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(02)00299-1","article-title":"Lithium and valproic acid: parallels and contrasts in diverse signaling contexts","volume":"96","author":"Gurvich","year":"2002","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00249-002-0218-2","article-title":"Hypoxia and persistent sodium current","volume":"31","author":"Hammarstrom","year":"2002","journal-title":"European Biophysics Journal"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.0022-3042.2001.00728.x","article-title":"Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation","volume":"80","author":"Hashimoto","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-2952(03)00187-4","article-title":"Search for a common mechanism of mood stabilizers","volume":"66","author":"Harwood","year":"2003","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1432-1033.1982.tb06896.x","article-title":"Phosphorylation of the type-II regulatory subunit of cyclic-AMP-dependent protein kinase by glycogen synthase kinase 3 and glycogen synthase kinase 5","volume":"127","author":"Hemmings","year":"1982","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1085\/jgp.59.6.637","article-title":"The permeability of the sodium channel to metal cations in myelinated nerve","volume":"59","author":"Hille","year":"1972","journal-title":"Journal of General Physiology"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0039-9140(97)00017-9","article-title":"A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability","volume":"44","author":"Ishiyama","year":"1997","journal-title":"Talanta"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neuropharm.2004.11.010","article-title":"Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death","volume":"48","author":"Jin","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0165-6147(03)00206-2","article-title":"Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes","volume":"24","author":"Jope","year":"2003","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/j.1460-2075.1995.tb07091.x","article-title":"Structure and\u00a0functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells","volume":"14","author":"Klugbauer","year":"1995","journal-title":"EMBO Journal"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib17","first-page":"1073","article-title":"Standards of laboratory practice: antidepressant drug monitoring","volume":"44","author":"Linder","year":"1998","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.06.053","article-title":"Constitutive activity of glycogen synthase kinase-3\u03b2: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells","volume":"1110","author":"Nemoto","year":"2006","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib19","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00001756-199806220-00031","article-title":"Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats","volume":"9","author":"Nonaka","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199409013310907","article-title":"Lithium in the treatment of mood disorders","volume":"331","author":"Price","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib21","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1073\/pnas.0937423100","article-title":"Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia\/reperfusion model","volume":"100","author":"Ren","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.860126","article-title":"Lithium ion entry through the sodium channel of cultured mouse neuroblastoma cells: a biochemical study","volume":"196","author":"Richelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.2000.4169","article-title":"Lithium inhibits glycogen synthase kinase-3 by competition for magnesium","volume":"280","author":"Ryves","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0278-5846(01)00154-3","article-title":"The mechanism of lithium action: state of the art, ten years later","volume":"25","author":"Shaldubina","year":"2001","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-6147(00)89060-4","article-title":"Na+ channels as targets for neuroprotective drugs","volume":"16","author":"Taylor","year":"1995","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib27","first-page":"21","article-title":"Pharmacological modulation of voltage-gated Na+ channels: a rational and effective strategy against ischemic brain damage","volume":"48","author":"Urenjak","year":"1996","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00228395","article-title":"Valproate and sodium currents in cultured hippocampal neurons","volume":"93","author":"Van den Berg","year":"1993","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1986.tb03525.x","article-title":"Valproate reduces excitability by blockage of sodium and potassium conductance","volume":"27","author":"VanDongen","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00515553","article-title":"Modulation by ouabain and diphenylhydantoin of veratridine-induced 22Na influx and its relation to 45Ca influx and the secretion of catecholamines in cultured bovine adrenal medullary cells","volume":"328","author":"Wada","year":"1985","journal-title":"Naunyn Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib31","first-page":"1347","article-title":"Cooperative modulation of voltage-dependent sodium channels by brevetoxin and classical neurotoxins in cultured bovine adrenal medullary cells","volume":"263","author":"Wada","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib32","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2741\/1314","article-title":"Regulation of cell surface expression of voltage-dependent NaV1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cells","volume":"9","author":"Wada","year":"2004","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.CRJ05009X","article-title":"Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases","volume":"99","author":"Wada","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib34","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1073\/pnas.96.14.7635","article-title":"Sodium channels and pain","volume":"96","author":"Waxman","year":"1999","journal-title":"Proceedings of the National Academy of Science"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(94)91967-4","article-title":"Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials","volume":"664","author":"Weber","year":"1994","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0169-328X(99)00338-1","article-title":"Increased neuronal excitability after long-term O2 deprivation is mediated mainly by sodium channels","volume":"76","author":"Xia","year":"2000","journal-title":"Molecular Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib37","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.STR.0000066308.25088.64","article-title":"Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death","volume":"34","author":"Xu","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1046\/j.1471-4159.1996.67041401.x","article-title":"Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells","volume":"67","author":"Yamamoto","year":"1996","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib39","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1046\/j.1471-4159.2000.0741674.x","article-title":"Protein kinase C-\u03b1 and -\u025b down regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells","volume":"74","author":"Yanagita","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.08.018_bib40","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/mol.63.5.1125","article-title":"Destabilization of NaV1.7 sodium channel \u03b1-subunit mRNA by constitutive phosphorylation of extracellular signal-regulated kinase: negative regulation of steady-state level of cell surface functional sodium channels in adrenal chromaffin cells","volume":"63","author":"Yanagita","year":"2003","journal-title":"Molecular Pharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T14:09:55Z","timestamp":1655561395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807002742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0028390807002742"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.08.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}